Finasteride + Minoxidil Combination: Clinical Trial Evidence

Finasteride and minoxidil act via complementary mechanisms — finasteride blocks DHT-mediated follicle miniaturization while minoxidil acts as a vasodilator and direct growth stimulator. Multiple trials and meta-analyses have investigated whether combining both agents produces superior outcomes to either monotherapy.

Key Evidence

Study	Design	n	Duration	Key Finding
Hu R, et al. 2015	Prospective RCT; 4 arms: fin alone, min alone, combination, control	101	12 months	Combination group showed significantly greater hair density improvement than either monotherapy arm; statistically significant on terminal hair count
Badri T, et al. 2021 (meta-analysis)	Systematic review and meta-analysis; 8 RCTs included	Pooled ~1,100	6–24 months	Combination therapy had greater hair count improvements vs. finasteride monotherapy; absolute difference was modest in some studies
Kinoshita-Ise M et al. 2022	Retrospective cohort; Japanese men	430	12 months	Combination associated with superior outcomes vs. monotherapy at 12 months; effect size limited for late-stage AGA

Evidence Summary

• Combination therapy is generally superior to monotherapy for hair density outcomes
• The absolute advantage is real but moderate; patients with early-to-moderate AGA may benefit most
• Both agents are FDA-approved for male AGA individually; combination use is common clinical practice though not officially labeled

Full guide: Finasteride and minoxidil combination therapy | Finasteride vs. minoxidil comparison

Sources

• Hu R, et al. “Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study on efficacy and safety.” J Dermatol. 2015;42(1):83–91.
• Badri T, et al. “Minoxidil.” In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.